This will be Maddie’s first event with the MMRF. She is looking forward to a week of cycling in honor of her dad who passed away from multiple myeloma in March of 2020. She and her dad went on many adventures together, even after his diagnosis, and he was always her biggest fan. Maddie competed on her collegiate cycling team, and though she doesn’t ride as much as she did during that season, she’s excited to be out on the road again and pushing herself in honor of her dad, who was the strongest person she ever knew. She’s thankful for opportunities to support ongoing research and provide other patients and their families with hope or a better future and more years together.
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.
About Janssen OncologyClick below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.
Learn More
